Outpace Bio (Series A)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$150,000,000
Company Info
Founders
Marc Lajoie
Market
Healthcare & Wellness
Coinvestors
Playground Global
Company Description

Tailored cell therapy solutions through protein design and custom programming. Outpace Bio is a biotechnology company that is revolutionizing cell therapy with protein design.